Clinical Trials Sponsored by Orient Europharma Co., Ltd.

Total 32 results

Orient Europharma Co., Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of 2ccPA in Patients With Symptomatic Knee Osteoarthritis

Osteoarthritis, Knee

Taiwan
Orient Europharma Co., Ltd.

Completed

2ccPA Study in Patients With Symptomatic Knee Osteoarthritis

Osteoarthritis (OA) of the Knee

Taiwan
Orient Europharma Co., Ltd.

Completed

Pharmacokinetic and Pharmacodynamic Study of Glufast Tablets 10mg(Mitiglinide)

Type 2 Diabetes Mellitus | Liver Dysfunction

Taiwan
Orient Europharma Co., Ltd.

Completed

Evaluate the Effect of Dietary Supplement on Muscle Mass and Physical Performance for Over 50 Years Old People

Muscle Loss

Taiwan
Orient Europharma Co., Ltd.

Recruiting

Evaluate the Effect of Dietary Supplement Combined Exercise Among Patients With Sarcopenia Comorbid With Lung Disease

Sarcopenia | COPD | ILD

Taiwan
Orient Pharma Co., Ltd.
Orient Europharma Co., Ltd.

Completed

Efficacy and Safety Study of Pitavastatin for Hypercholesterolemia

Hypercholesterolemia

Taiwan
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Terminated

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Pancreatic Neoplasms

Taiwan, Japan, Hong Kong, Singapore, Philippines, Malaysia, Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Recruiting

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

SCCHN

Croatia, Czechia, Hungary, Poland, Russian Federation, Serbia, Taiwan, Ukraine
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore
Medinox, Inc.
Orient Europharma Co., Ltd.

Completed

NOX-100 for Preventing Hypotension During Hemodialysis

Hypotension

Taiwan
AndroScience Corp
Orient Europharma Co., Ltd.

Completed

Topical ASC-J9 Cream for Acne

Acne

United States, Taiwan
Far Eastern Memorial Hospital
Orient Europharma Co., Ltd.

Unknown

Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications

Asthma

Taiwan
Orient Pharma Co., Ltd.

Completed

A Relative Efficacy and Safety Study of OC Oral Solution for Sialorrhoea in Patients With Parkinson's Disease

Sialorrhoea

United States
Orient Pharma Co., Ltd.

Completed

Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia

Primary Hypercholesterolemia | Mixed Dyslipidemias

Taiwan, Australia, New Zealand
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
CEL-SCI Corporation
Teva Branded Pharmaceutical Products R&D, Inc.; Orient Europharma Co., Ltd.

Completed

Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity (IT-MATTERS)

Squamous Cell Carcinoma of the Oral Cavity | Squamous Cell Carcinoma of the Soft Palate

Spain, Taiwan, United States, United Kingdom, Romania, India, Croatia, Belarus, Hungary, Bosnia and Herzegovina, Russian Federation, Austria, Canada, France, Israel, Italy, Malaysia, Poland, Serbia, Sri Lanka, Thailand, Turkey, Ukraine
Orient Pharma Co., Ltd.
Durect

Completed

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
Qurient Co., Ltd.

Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor in Patients With Advanced Solid Tumor

Solid Tumor | Metastatic Cancer | Advanced Cancer

United States
Qurient Co., Ltd.

Completed

A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203)

Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB

South Africa
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Multiple Doses of Q203 in Normal Healthy Male and Female Volunteers

Healthy Volunteers

United States
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Moderate to Severe Atopic Dermatitis

United States
Qurient Co., Ltd.

Terminated

A Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec (Q203) in Covid-19 Patients

COVID-19 Virus Infection

South Africa
Qurient Co., Ltd.

Completed

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Atopic Dermatitis

United States
Qurient Co., Ltd.

Completed

A Dose-Escalation Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Doses of Q203 in Normal, Healthy, Male and Female Volunteers

Healthy Volunteers

United States
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Participants With Neovascular Age-related Macular Degeneration

Age-Related Macular Degeneration

United States
Chengdu Origen Biotechnology Co., Ltd.

Recruiting

Safety and Tolerability of KH631 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Age-Related Macular Degeneration

China
Qurient Co., Ltd.
Merck Sharp & Dohme LLC

Recruiting

Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors

Cervical Cancer | Gastric Cancer | Esophageal Cancer | Hepatocellular Cancer

Korea, Republic of, United States
Qurient Co., Ltd.
Merck Sharp & Dohme LLC

Recruiting

Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid Tumors

Metastatic Cancer | Advanced Cancer

United States, Korea, Republic of
Orient Pharma Co., Ltd.
National Defense Medical Center, Taiwan; National Research Program for Biopharmaceuticals...

Completed

Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis

Pulmonary Tuberculosis

Taiwan
Puren Hospital Affiliated to Wuhan University of...
Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Shanghai... and other collaborators

Unknown

Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia

COVID-19

China
Prof. Tobias Feuchtinger
European Commission; Simbec-Orion Group Ltd, Merthyr Tydfil, UK; Miltenyi Biotec... and other collaborators

Recruiting

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections (TRACE)

CMV Infection | EBV Infection | Stem Cell Transplant Complications | AdV Infection

Belgium, Spain, France, Germany, Italy, Netherlands

Clinical Trials Sponsored by Orient Europharma Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations